Trexquant Investment LP Repligen Corp Transaction History
Trexquant Investment LP
- $7.59 Billion
- Q3 2024
A detailed history of Trexquant Investment LP transactions in Repligen Corp stock. As of the latest transaction made, Trexquant Investment LP holds 37,517 shares of RGEN stock, worth $5.34 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
37,517Holding current value
$5.34 Million% of portfolio
0.07%Shares
6 transactions
Others Institutions Holding RGEN
# of Institutions
488Shares Held
54.3MCall Options Held
350KPut Options Held
184K-
Black Rock Inc. New York, NY7.57MShares$1.08 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$910 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$718 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$231 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$202 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.9B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....